“Cephamycin-Based Antisporulation Agents Targeting Clostridioides difficile: Development of Lead Compound 6a with Enhanced Potency and Limited Off-target Effects”

https://pubmed.ncbi.nlm.nih.gov/38112278

Researchers designed, synthesized, and evaluated cephamycin-based antisporulation agents targeting Clostridioides difficile, with lead compound 6a showing promise as a potential drug development candidate due to its enhanced potency and limited off-target effects.